GLECAPREVIR AND PIBRENTASVIR

N/A

Manufactured by AbbVie Inc.

15,159 FDA adverse event reports analyzed

Last updated: 2026-04-14

About GLECAPREVIR AND PIBRENTASVIR

GLECAPREVIR AND PIBRENTASVIR is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by AbbVie Inc.. The most commonly reported adverse reactions for GLECAPREVIR AND PIBRENTASVIR include FATIGUE, HEADACHE, NAUSEA, PRURITUS, DIARRHOEA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for GLECAPREVIR AND PIBRENTASVIR.

Top Adverse Reactions

FATIGUE2,561 reports
HEADACHE2,203 reports
NAUSEA1,125 reports
PRURITUS653 reports
DIARRHOEA477 reports
RASH311 reports
VOMITING308 reports
DIZZINESS231 reports
DEATH222 reports
PAIN209 reports
INSOMNIA201 reports
ABDOMINAL DISCOMFORT197 reports
DRUG INEFFECTIVE178 reports
ASTHENIA158 reports
ABDOMINAL PAIN UPPER149 reports
DYSPNOEA147 reports
THERAPY CESSATION144 reports
ABDOMINAL PAIN140 reports
CONSTIPATION139 reports
ARTHRALGIA133 reports
DRUG DOSE OMISSION131 reports
PRODUCT DOSE OMISSION127 reports
FEELING ABNORMAL121 reports
SOMNOLENCE117 reports
DECREASED APPETITE114 reports
DEPRESSION112 reports
PERIPHERAL SWELLING107 reports
ANXIETY106 reports
HOSPITALISATION104 reports
PNEUMONIA100 reports
DYSPEPSIA99 reports
HEPATIC CIRRHOSIS98 reports
ALOPECIA97 reports
NASOPHARYNGITIS96 reports
BACK PAIN91 reports
MYALGIA87 reports
PYREXIA84 reports
WEIGHT DECREASED84 reports
BLOOD BILIRUBIN INCREASED83 reports
ABDOMINAL DISTENSION80 reports
FALL80 reports
MATERNAL EXPOSURE DURING PREGNANCY80 reports
MALAISE79 reports
HEPATITIS C78 reports
URTICARIA78 reports
CHROMATURIA77 reports
PAIN IN EXTREMITY76 reports
COUGH74 reports
MUSCLE SPASMS74 reports
DRY SKIN72 reports
URINARY TRACT INFECTION71 reports
DRUG INTERACTION70 reports
MIGRAINE70 reports
WEIGHT INCREASED70 reports
MEMORY IMPAIRMENT66 reports
INFLUENZA LIKE ILLNESS63 reports
DEHYDRATION61 reports
OFF LABEL USE61 reports
CONDITION AGGRAVATED60 reports
INCORRECT DOSE ADMINISTERED60 reports
ADVERSE DRUG REACTION57 reports
INFLUENZA57 reports
TREATMENT FAILURE57 reports
HYPERHIDROSIS55 reports
CHEST PAIN54 reports
DRY MOUTH53 reports
INFECTION53 reports
VISION BLURRED53 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION52 reports
BLOOD PRESSURE INCREASED51 reports
FLATULENCE50 reports
SWELLING FACE50 reports
HYPERTENSION49 reports
HYPERSENSITIVITY48 reports
SEIZURE48 reports
THERAPY INTERRUPTED48 reports
LOSS OF CONSCIOUSNESS47 reports
UNEVALUABLE EVENT46 reports
CEREBROVASCULAR ACCIDENT45 reports
ACUTE KIDNEY INJURY44 reports
RASH PRURITIC44 reports
VIRAL LOAD INCREASED44 reports
DYSPHAGIA43 reports
HYPOAESTHESIA43 reports
BLOOD GLUCOSE INCREASED42 reports
TREMOR42 reports
CONFUSIONAL STATE41 reports
CONTUSION41 reports
GASTROOESOPHAGEAL REFLUX DISEASE41 reports
JAUNDICE41 reports
ILLNESS40 reports
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS40 reports
FAECES DISCOLOURED39 reports
OEDEMA PERIPHERAL38 reports
CHRONIC OBSTRUCTIVE PULMONARY DISEASE37 reports
IRRITABILITY37 reports
MYOCARDIAL INFARCTION37 reports
ASCITES36 reports
HOT FLUSH36 reports
LETHARGY36 reports

Report Outcomes

Out of 10,811 classified reports for GLECAPREVIR AND PIBRENTASVIR:

Serious 25.4%Non-Serious 74.6%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Male5,302 (52.9%)
Female4,720 (47.1%)
Unknown3 (0.0%)

Reports by Age

Age 60385 reports
Age 63354 reports
Age 58338 reports
Age 62335 reports
Age 59332 reports
Age 61303 reports
Age 64275 reports
Age 56264 reports
Age 57262 reports
Age 65230 reports
Age 55229 reports
Age 54203 reports
Age 53197 reports
Age 66176 reports
Age 52166 reports
Age 40165 reports
Age 50152 reports
Age 67146 reports
Age 51130 reports
Age 29126 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with GLECAPREVIR AND PIBRENTASVIR?

This profile reflects 15,159 FDA FAERS reports that mention GLECAPREVIR AND PIBRENTASVIR. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for GLECAPREVIR AND PIBRENTASVIR?

Frequently reported terms in FAERS include FATIGUE, HEADACHE, NAUSEA, PRURITUS, DIARRHOEA, RASH. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures GLECAPREVIR AND PIBRENTASVIR?

Labeling and FAERS entries often list AbbVie Inc. in connection with GLECAPREVIR AND PIBRENTASVIR. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.